From 1 September 2026, the prescriber accreditation requirement for hepatitis B medicines under the PBS Section 100 (s100) Highly Specialised Drugs Program will be removed. As a result, all medical and authorised nurse practitioners will be able to prescribe hepatitis B antiviral treatment without additional specialist accreditation. ASHM is currently updating its website, education and resources to reflect this change.
ASHM works with healthcare professionals and leading experts to produce clinical resources, tools, and awareness-raising campaigns around the prevention and treatment of hepatitis C.
Towards the elimination of hepatitis C through collaboration and education
Providing reliable advice on hepatitis C testing and treatment through clinical practice tools and guidelines.
Empowering healthcare workers with the knowledge to manage and cure hepatitis C in primary care settings.
Collaborating with general practices to expand hepatitis C case-finding efforts and connect more people to the care.
Number of hepatitis C courses and forums (includes OLMS, f2f courses, and forums)
Health professionals who have taken ASHM hepatitis C training (number of attendees at hepatitis C courses)
Hepatitis C resources developed (guidelines, OLMs, Beyond the C resources)
This Testing Policy has been developed as a concise source of standardised, currently available information to inform those involved in ordering and performing hepatitis C testing.
Decision Making in Hepatitis C resource is a 2-page guide designed to support general practitioners (GPs), nurse practitioners, and other primary care providers in effectively managing hepatitis C. This resource provides a concise yet comprehensive overview of the diagnosis, treatment, and follow-up of hepatitis C, empowering healthcare professionals to deliver optimal care to their patients.
Beyond the C is a national partnership program with General Practice, to find people who may be living with Hepatitis C, engage and connect them with care.